Loading...
MIDAS: A Practical Bayesian Design for Platform Trials with Molecularly Targeted Agents
Recent success of immunotherapy and other targeted therapies in cancer treatment has led to an unprecedented surge in the number of novel therapeutic agents that need to be evaluated in clinical trials. Traditional phase II clinical trial designs were developed for evaluating one candidate treatment...
Saved in:
| Published in: | Stat Med |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2016
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5012931/ https://ncbi.nlm.nih.gov/pubmed/27112322 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/sim.6971 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|